DEBBIE PAGE: Open Payments
NPI 1619632973 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,082 in 56 payments from 16 companies in 2025. Trend: 2023 $1,803 · 2024 $1,299 · 2025 $1,082
Food & beverage: $1,082
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $216 |
| AstraZeneca Pharmaceuticals LP | 4 | $169 |
| Corcept Therapeutics | 10 | $152 |
| GlaxoSmithKline, LLC. | 6 | $122 |
| Lilly USA, LLC | 4 | $79 |
| ABBVIE INC. | 4 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| PFIZER INC. | 2 | $39 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Dexcom, Inc. | 2 | $30 |
Products named: Korlym, Ozempic, TRELEGY ELLIPTA, BREZTRI, XIFAXAN, Wegovy, AIRSUPRA, UBRELVY.
Industry payments across AZ — which companies pay providers there.
